China's medical products administrator approved Shanghai Fosun Pharmaceutical (SHA:600196, HKG:2196) subsidiary Hunan Dongting Pharmaceutical's oxazepam tablets for anxiety relief, according to a Monday filing with the Hong Kong Exchange.
The drug is also indicated for nervousness, agitation, and for hypnosis, the filing said. It is also suitable for alcohol withdrawal symptom relief, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.